Aggressive treatment of atrial fibrillation in hypertrophic cardiomyopathy patients improve quality of life

J Cardiovasc Electrophysiol. 2024 Apr;35(4):664-666. doi: 10.1111/jce.16210. Epub 2024 Feb 8.

Authors

Gerald V Naccarelli¹, Eric D Popjes¹

Affiliation

¹ Penn State Heart and Vascular Institute, The Milton S. Hershey Medical Center, Penn State University College of Medicine Penn State Health, Hershey, Pennsylvania, USA.

PMID: 38332487
DOI: 10.1111/jce.16210

No abstract available

Keywords: antiarrhythmic drugs; atrial fibrillation; hypertrophic cardiomyopathy; quality of life.

Publication types

Editorial

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / surgery
Cardiomyopathy, Hypertrophic* / complications
Cardiomyopathy, Hypertrophic* / diagnosis
Cardiomyopathy, Hypertrophic* / therapy
Humans
Quality of Life

Substances

Anti-Arrhythmia Agents